Wednesday, February 13, 2019
Why (or why not) take in new capital?
It’s been a remarkable time in private capital markets. The sheer amount of capital available and “chasing” opportunities has driven up valuations. Innovation and flexibility on the capital side have created more opportunities for entrepreneurs to do the kind of deal they really want, rather than just take what’s being offered. With that background, it’s […]
Friday, June 20, 2014
Healthcare M&A: Big deals getting all the attention
2014 has to go down as the year of the big announcement (it may also be remembered as the year of the failed Pfizer bid for AstraZeneca). One might think these mega deals are crowding out middle market activity. But that’s only true in the newspapers. In fact, there have been over 1,000 healthcare deals […]
Recent Comments